Evidence map›Paper›PMID 24054997›Full record

ArticleArchives of medical research2013

Association between rs2981582 polymorphism in the FGFR2 gene and the risk of breast cancer in Mexican women.

Efrén Murillo-Zamora, Hortensia Moreno-Macías, Elad Ziv, Isabelle Romieu, Eduardo Lazcano-Ponce, Angélica Angeles-Llerenas, Edelmiro Pérez-Rodríguez, Silvia Vidal-Millán, Laura Fejerman, Gabriela Torres-Mejía

Open access · greenAbstract read
In one paragraph

Article in Archives of medical research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Determination ofDisease markers · 2019
    Article
  8. Disability-Adjusted Life Years for Cancer in 2010⁻2014: A Regional Approach in Mexico.International journal of environmental research and public health · 2018
    Article
  9. Review
  10. Association ofOncology letters · 2017
    Article
  11. Fibroblast Growth Factor Receptor 2 Signaling in Breast Cancer.International journal of biological sciences · 2017
    Review
  12. Genomic Disparities in Breast Cancer Among Latinas.Cancer control : journal of the Moffitt Cancer Center · 2016
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Efrén Murillo-ZamoraDepartamento de Epidemiología, Hospital No. 4, IMSS, Tecomán, Colima, Mexico.
Hortensia Moreno-Macías
Elad Ziv
Isabelle Romieu
Eduardo Lazcano-Ponce
Angélica Angeles-Llerenas
Edelmiro Pérez-Rodríguez
Silvia Vidal-Millán
Laura Fejerman
Gabriela Torres-Mejía
Instituto Nacional de Salud Pública · MXUCSF Helen Diller Family Comprehensive Cancer Center · USCentre International de Recherche sur le Cancer · FRHospital Universitario Dr José Eleuterio Gonzalez · MXInstituto Nacional de Cancerología · MXUniversidad Autónoma Metropolitana · MX

Funding

Genome wide association study of breast cancer subtype and survival in LatinasK01CA160607 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FEJERMAN, LAURA · 2011 to 2015
$629k
NCI NIH HHS K01 CA160607
6 · The paper itself

Abstract

BACKGROUND AND

aimsThe rs2981582 single nucleotide polymorphism in the fibroblast growth factor receptor 2 gene has been consistently associated with an increased risk of breast cancer. We evaluated the effect of rs2981582 polymorphism in the FGFR2 gene on the risk of breast cancer and its interaction with non-genetic risk factors.

methodsA population-based case-control study was conducted in Mexico. Data from 687 cases and 907 controls were analyzed.

resultsThe T allele of the rs2981582 polymorphism was associated with an increased risk of breast cancer (ORper allele = 1.24, 95% CI 1.06-1.46). There was also an interaction between this polymorphism and alcohol consumption (p = 0.043). The effect of alcohol consumption on the risk of breast cancer varied according to the allelic variants of the rs2981582 polymorphism in the FGFR2 gene: OR = 3.97 (95% CI 2.10-7.49), OR = 2.01 (95% CI 1.23-3.29) and OR = 1.21 (95% CI 0.48-3.05) for genotypes CC, CT and TT, respectively.

conclusionsThis is the first study exploring the association between rs2981582 polymorphism in the FGFR2 gene and breast cancer risk in Mexican women. The interaction found may be of great public health interest because alcohol consumption is a modifiable breast cancer risk factor. Therefore, replication of this finding is of foremost importance.

Indexed as

Polymorphism, Single NucleotideAdultAlcohol DrinkingAllelesBreast NeoplasmsCase-Control StudiesComorbidityDiabetes MellitusFemaleGene-Environment InteractionGenetic Predisposition to DiseaseGenotypeHumansMexicoMiddle AgedParityReceptor, Fibroblast Growth Factor, Type 2Breast cancerFGFR2 geners2981582 single nucleotide polymorphism

Identifiers

PMID24054997
PMCPMC4049087
OpenAlexW2133935791

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.